Clinical Trials Directory

Trials / Unknown

UnknownNCT04609605

Assessment of Right Ventricular Function After Acute Pulmonary Embolism Using Speckle Tracking Echocardiography

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

1. To asses regional RV function in patients presented with acute pulmonary embolism using speckle tracking echocardiography 2. To evaluate its relationship to long term mortality.

Detailed description

Pulmonary embolism (PE) is the third most common cardiovascular cause of death after myocardial infarction and stroke . The incidence of PE has been increasing ,with significant associated mortality; a recent registry of PE patients reported a mortality rate \> 10% at 30 days. There are a number of emerging contemporary PE therapies, including thrombolysis, catheter intervention and surgery. Early and accurate identification of PE in patients is therefore critical. A transthoracic echocardiogram (TTE) may help when there is a clinical suspicion for PE, and its use in confirmed PE is widely recommended . A number of right atrial (RA) and right ventricular (RV) parameters have been shown to be abnormal in patients with PE . In addition, RA and RV enlargement portends a worse prognosis in these patients .

Conditions

Interventions

TypeNameDescription
DEVICEspeckle tracking echocardiographyspeckle tracking echocardiography of right ventricle

Timeline

Start date
2020-12-01
Primary completion
2021-12-01
Completion
2022-01-01
First posted
2020-10-30
Last updated
2020-11-03

Source: ClinicalTrials.gov record NCT04609605. Inclusion in this directory is not an endorsement.